Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03150095 · ClinicalTrials.gov registry record · NA

Health Coaching to Improve Self-Management in Thoracic Transplant Candidates

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT03150095: Completed NA study, sponsored by Mayo Clinic.

NCT03150095 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03150095, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Ability to adhere to complex medical regimens is critical to achieving successful transplant outcomes, as non-adherent patients suffer graft failure and death following transplantation. Since potential recipients greatly exceed organ availability, identification of candidates who will adhere to complex post-transplant regimens is critically important and emphasized by practice guidelines. When selecting candidates for transplant, physicians try to subjectively predict post-transplant adherence because, although tools exist to measure current adherence, tools that reliably predict future adherence are lacking. Despite rigorous medical and psychosocial screening pretransplant, non-adherence rates are high following transplant. Therefore, the current approach for predicting future non-adherence is suboptimal, subjective, and greatly needs strategies for improvement. Pre-transplant self-management abilities represent a marker of future adherence post-transplant. Assessing self-management as a means for predicting future adherence has been largely overlooked. Self-management is defined as "taking responsibility for one's own behavior and well-being" and consists of three management tasks: medical condition, emotions, and social roles. Self-management ability can be measured. However, self-management has not been systematically studied in heart and lung transplant patients. Fostering self-management abilities may improve post-transplant outcomes by optimizing not only adherence, but also proven pretransplant risk factors (e.g. frailty and obesity).Self-management abilities may be improved via behavioral interventions such as health coaching.Self-management represents a measurable criterion that could be utilized in pre-transplant screening and serve as a point of intervention for optimizing adherence and pre-transplant risk factors.The overall objective of the proposed research is to improve the knowledge gap regarding self-management (and thereby adherence) in transplan

Primary Outcome

The 30 Item Self-Management Ability Scale (SMAS-30) measures self-management based on questions from 6 subsets of Taking Initiatives, Investment Behavior, Variety, Multifunctionality, Self-efficacy, and Positive Frame of Mind. These are totaled into a scale ranging from 0-100. Higher scores indicate better self-management ability.

Interventions

  • BEHAVIORAL Health coaching

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-10-25
Est. Completion 2021-11-02
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03150095 record still lists

NCT03150095 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Health coaching is the first listed.

NCT03150095 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03150095 about?

NCT03150095 is a clinical study titled "Health Coaching to Improve Self-Management in Thoracic Transplant Candidates". Ability to adhere to complex medical regimens is critical to achieving successful transplant outcomes, as non-adherent patients suffer graft failure and death following transplantation. Since potential recipients greatly exceed organ availability, identification of candidates who will adhere to comp...

What is the current status of trial NCT03150095?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-10-25. Estimated completion is 2021-11-02.

What interventions are being tested in trial NCT03150095?

The interventions under investigation include: Health coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT03150095?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03150095's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03150095, the US trial registry maintained by the National Library of Medicine. NCT03150095 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.